Alodokter Introduces "Aloshop" Online Pharmacy Service

Some time ago, platform healtech Alodokter introduces services epharmacy the latest Aloshop which is integrated directly in the application. Currently only available in most areas of Jakarta and Bekasi, but the network will be expanded nationally in March 2021.

According to the information shared Alodokter Co-Founder & CEO Nathanael Faibis, Aloshop is referred to as epharmacy first fully committed to partner with supply chain leaders trusted in Indonesia. Aloshop also offers a business model that sustainable with affordable product prices in the range of 5%-20% in the market epharmacy Indonesia.

Contacted DailySocial Separately, President Director of Alodokter Suci Arumsari said Aloshop is here to meet the needs of health products for 31 million Alodokter users. His party will work with strategic partners who are trusted and have a good reputation in terms of providing medicines to ensure the quality and authenticity of the products.

"Currently, Aloshop is collaborating with a strategic partner that we have not been able to reveal to join [in Aloshop]. In the future, we will continue to evaluate the needs of our users so that we can work with other trusted partners," he said.

Suci revealed, Alodokter is currently in the process of strengthening the network of drug and health product providers so that the supply can be carried out efficiently. In addition, his party is also conducting system integration with a national-scale courier company to improve the product delivery network at Aloshop.

"Through our long-term plans with strategic partners, we strive to provide complete services and the best prices and are easily accessible to Alodokter users. We ensure cooperation with strategic partners can be mutually beneficial so that each party can grow together," he said.

Through the Alodokter application, users can transact at Aloshop, whether using a doctor's prescription or not. For purchases with a doctor's prescription, users must first consult with a doctor through the Alodokter application. This is done by Alodokter to maintain the validity and safety of prescribing and treatment.

Suci said that Alodokter already has a team to curate over-the-counter medicines, vitamins, and supplements that do not require a prescription in accordance with government regulations. In addition, Aloshop also provides prescription drugs, beauty and skin health products, and products for the needs of mothers and children.

"All products available at AloShop are curated products that meet government regulatory standards, as regulated in BPOM regulation No. 8 of 2020," added Suci.

Based on Similarweb's current ranking, Alodokter still tops the rankings for services healthtech in Indonesia. As of November 2020, Alodokter has secured series C . funding worth $33 million from a number of investors, such as MDI Ventures, Sequis, to Golden Gate Ventures.

Growth healthtech and epharmacy in times of pandemic

Services epharmacy is an inseparable part of the ecosystem healthtech. In this case, service epharmacy become an important strategy in connecting the community to health services from upstream to downstream.

Moreover, currently access to health in Indonesia is still minimal. With the current economic conditions, not all people are able to obtain the same care and health products in every region.

In Indonesia, a number of businesses in the pharmaceutical industry have started to develop their own similar service platforms, such as: k24click owned by the K24 pharmacy network to the pharmaceutical giant Kalbe through the platform KALCare.

As for the Covid-19 pandemic, healthtech to be one of the services that has experienced significant growth, not only in Indonesia, but also in Southeast Asia. One of these achievements was validated in the latest report by Google, Temasek, and Bain & Company in e-Conomy SEA 2020.

Based on research Market Data Forecasts, pass epharmacy in the world showing significant growth due to policy lockdown. Epharmacy considered to be the right and safer option in order to reduce the rate of the spread of Covid-19. Research shows that around 30-40 percent of purchases of medicines or health products have been made through digital platforms since the start of the pandemic.